The Association of Vitamin D Dietary Intake and Type 2 Diabetes Among African Americans in Central Ohio by Ng, Sin Nee
 
 
 
 
The Association of Vitamin D Dietary 
Intake and Type 2 Diabetes  
Among African Americans in 
 Central Ohio 
 
 
 
By 
Sin Nee Ng 
 
 
The Ohio State University 
Department of Human Nutrition 
May 2014 
 
Project Advisor: Julie A. Kennel, PhD, RD, LD 
Director, Dietetic Internship,  
Department of Human Sciences 
 
 
 
 
 
 
 
 
 
 2 
 
Table of Contents 
 
 Abstract…………………………………………………………………………………....3 
 Introduction……………………...…….…………………………….………………….....4 
 Literature Review……………………………………………………………………….....5 
 Materials and Methods…………………………….……………………………………...11 
 Results…………………………….…………………………….………………………...13 
 Discussion…………………………….…………………………….…………………….15 
 Conclusions and Implications…………………………….………………………………17 
 References…………………………….…………………………….…………………….19 
 Appendix A………………………….…………………………….………………………22
 Appendix B………………………….…………………………….………………………23 
 Appendix C………………………….…………………………….………………………24 
 Appendix D………………………….…………………………….………………………25 
   
 3 
Abstract 
 Vitamin D deficiency is recognized as a serious health issue. Studies show vitamin D 
intake levels among African Americans are below Adequate Intakes (IOM). African 
Americans have higher incidence of vitamin D deficiency, and are two times more likely to 
develop Type 2 Diabetes (T2D) compared to other ethnic groups. Studies are inconsistent as 
to whether vitamin D deficiency is associated with T2D. In this study, we investigated the 
association of vitamin D dietary intake and T2D diagnosis among African American adults in 
Central Ohio. We hypothesized that African Americans with T2D have lower vitamin D 
intake levels, and thereby, higher risk of vitamin D deficiency, compared with those who do 
not have T2D. In this cross-sectional study, we recruited participants (n=8 with T2D; n=15 
without T2D) from the Total Health and Wellness Clinic at The Ohio State University 
Hospital East. We used diagnosis data from the medical record to confirm T2D diagnosis 
(present/not present). Participants provided their dietary intake through short food frequency 
questionnaire to obtain vitamin D intake (IU/day). Other measures included serum 25-
hydroxyvitamin D (nmol/L), serum fasting glucose (mg/dL), HbA1C (%), used of nutritional 
supplements and medications, history of medical diagnoses, and sunlight exposure. We used 
unpaired t-tests to detect differences in vitamin D intake among those with and without T2D. 
Our results suggest that African Americans at a primary care clinic in Central Ohio with T2D 
tend to have lower vitamin D dietary intakes compared with people without T2D. All African 
Americans in our sample, regardless of diabetes diagnosis, reported extremely low dietary 
intake with an average intake of just 23% of the recommended RDA. Results from this study 
could be used to determine the need for nutrition intervention for African Americans with or 
at risk for T2D.  
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Introduction 
 Diabetes mellitus has become a significant global health problem among the nation 
nowadays. There are 347 million people in the worldwide suffering from diabetes and 90% of 
those people are with type 2 diabetes (T2D).1 In the United States, 25.8 million of children 
and adults, which account for 8.3% of the population, are having diabetes. In addition to that, 
79 million of the people are identified as pre-diabetes.2 The prevalence of diabetes is growing 
dramatically with an increased risk of life-threatening complications, and certain populations, 
especially African American minority group, experience an even greater threat. There are 4.9 
million, or 18.7% of all African Americans aged 20 years or above are diagnosed with 
diabetes. Compared to non-Hispanic whites, African Americans are 1.8 times more likely to 
have diabetes.3 An estimated 3.4 million people died from the complication of diabetes in 
year 2004, and it is subjected to be the 7th leading cause of death in 2030.1   
 There is a large amount of evidence suggesting that vitamin D deficiency could be a 
contributing factor that leads to the development of type 1 and type 2 diabetes. Research 
found that vitamin D plays an imperative role in the normal function of pancreatic islet, as the 
pancreas contains vitamin D receptors that respond to the active form of 1,25(OH)2D4. In in 
vivo and in vitro studies, vitamin D deficiency impaired insulin secretion from β cell and 
increased the risk of diabetes mellitus5, whereas vitamin D supplementation restored insulin 
secretion with improved β-cell function, insulin sensitivity, and attenuated the rise of 
hemoglobin A1C.6 On one hand, vitamin D has direct effect on insulin action by stimulating 
insulin receptor to enhance insulin responsiveness to glucose transport.7 This effect is further 
supported by the presence of vitamin D response element in human insulin gene promoter8 
and the transcriptional activation of human insulin gene modulated by 1,25(OH)2D9. On the 
other hand, an indirect effect of vitamin D on pancreatic β cell is mediated through the 
regulation of calcium that has effect on insulin secretion.7 
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 Vitamin D has been linked with skeletal health traditionally; however, there has been 
a recent growth in research that discovered vitamin D’s involvement in other body system as 
well. The modern history of vitamin D traced back to the mid-1800s, when it was found that 
city children were more prone to rickets than rural children.10 One and a half century later, 
Cedric Garland and Frank Garland of Johns Hopkins University hypothesized that exposure 
to ultraviolet B (UVB) radiation is associated with increased risk of developing colon cancer, 
while vitamin D and calcium could function to prevent the cancer in humans.10 Later, studies 
found that the active form of vitamin D, 1,25(OH)2D produced by kidney interacts with its 
nuclear receptor, called vitamin D receptor, in the intestine and bone to regulate calcium and 
bone metabolism.11,12 Most tissues and cells in the body, including heart, stomach, pancreas, 
brain, skin, gonads and activated T and B lymphocytes also contain vitamin D receptors that 
have enzymatic reaction with 1,25(OH)2D. Thus, it is not surprising that vitamin D has a 
noncalcemic function in the human body.13 In other words, vitamin D status is also associated 
with other medial conditions, such as cancer prevention, heart disease treatment, and most 
interestingly, it can improve glucose tolerance and may prevent or treat diabetes mellitus.14 
This cross-sectional study was aimed at investigating the relation of vitamin D dietary intake 
and type 2 diabetes among African Americans.  
Literature Review 
 Vitamin D, also known as the “sunshine vitamin”, is not technically a vitamin and it is 
not an essential dietary component; rather it is a group of fat-soluble pro-hormone that has 
molecular structure similar to that of classic steroid hormones.15 The precursor of vitamin D 
synthesis is the photochemical production of 7-dehydrocholesterol (provitamin D3) in the 
skin.15 The two main common forms of vitamin D are ergocalciferol (vitamin D2) and 
cholecalciferol (Vitamin D3).7 Vitamin D2 is synthesized by plants (mainly mushroom and 
yeast), while vitamin D3 is derived both endogenously through the exposure of ultraviolet B 
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light from sunlight and exogenously from animal food sources such as fatty fish and fish liver 
oils.7, 16 Both vitamin D2 and vitamin D3 can be made synthetically and are commonly used to 
fortify foods such as milk products, margarine, and to make dietary supplements.7,17  
 Vitamin D from sun exposure, food, and supplements are biologically inert and 
require two obligate hydroxylations in the liver and kidney for activation.18, 19 The first 
hydroxylation occurs in the liver where vitamin D is converted to 25-hydroxyvitamin D 
[25(OH)D], also known as calcidiol.19, 20 The second hydroxylation occurs in the kidney and 
forms 1,25-dihydroxyvitamin D [1,25(OH)2 D], also known as calcitriol, which needs to bind 
to vitamin D receptors in order to perform biological actions.19,20 Serum concentration of 
25(OH)D is the best indicator of vitamin D status obtained from cutaneous synthesis and total 
foods and supplements intake.16,21 Thus, 25(OH)D may function as a biomarker of exposure 
that examines the intake level of vitamin D plus exposure to sunlight and reflects the supply 
of vitamin D to the body.11 However, it is not clear to what extend 25(OH)D also serves as a 
biomarker to predict health outcomes.11 1,25(OH)2 D is not used in this case as an indicator of 
vitamin D status due to its short half-life and its formation does not directly regulated by 
vitamin D intake, but parathyroid hormone.11 
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Figure 1: Overview of Vitamin D synthesis, intake, and activation.9  
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 According to the US Institute of Medicine (IOM), serum 25(OH)D ≥ 20ng/mL is 
adequate to cover the needs of 97.5% of the population.16  Unfortunately, it is difficult to 
obtain adequate amount of vitamin D from food sources alone.11 Vitamin D has been taken 
for granted as the “sunshine vitamin”, until recently, when vitamin D deficiency (serum 
25(OH)D < 12ng/mL) has been recognized as an epidemic in the United States, especially 
among African Americans.11,22 There are many factors that affect serum 25(OH)D levels, 
including limited synthesis of vitamin D from the sunlight due to the usage of sunscreens, 
darker skin pigmentation, the effect of latitude and seasons.11 Other factors that may as well 
influence serum 25(OH)D level and cause vitamin D deficiency include dietary inadequacy 
especially those who are lactose intolerant, impaired absorption due to diseases and adiposity, 
and African American ethnicity.11  
 Sunlight exposure is the major source of cutaneous synthesis of vitamin D and can be 
affected under different circumstances, including the use of sunscreen, latitude, and seasonal 
variation.11 Sunscreens, which absorb the ultraviolet B (UVB) radiation and prevent it from 
reaching the skin, suppress cutaneous vitamin D synthesis.23 A sunscreen with a sun 
protection factor (SPF) of 15 absorbs 99% of the incident UVB radiation, which directly 
reduces the synthesis of vitamin D in the skin by 99%.24 In the meanwhile, melanin is a skin 
pigment found in organisms that acts as a natural sunscreen to protect skin from UVB 
radiation damage. This skin pigment will compete with 7-dehydrocholesterol for UVB 
photons and limit vitamin D synthesis.25 Therefore, people with greater amount of melanin in 
their epidermis, i.e. African Americans, are less efficient in producing vitamin D than the 
whites.25 For the factor of latitude, little serum 25(OH)D is produced from cutaneous 
synthesis at latitude above 43°N during the winter months between October and March in 
North America.11 However, according to the recent data, geographic latitude alone does not 
consistently predict serum 25(OH)D level in the population. Even in the far north latitude, 
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there are ample opportunities during spring, summer, and fall months to synthesis vitamin D 
from sunlight exposure that can be stored in the liver and fat.26   
 Even though foods with fortified vitamin D are available, they are often inadequate to 
meet either a child’s or an adult’s vitamin D requirement.19 Infants and elder adults are the 
two major groups that are at risk of low vitamin D levels due to inadequate vitamin D intake. 
Human breast milk alone does not provide infants with adequate intake of vitamin D.11 
Therefore, the American Academy of Pediatrics (AAP) recommends a daily intake of vitamin 
D of 400IU/day is needed for all breastfed infants.11 While for older adults, due to aging, their 
skin cannot synthesize vitamin D as efficiently, and at the same time both men and women 
experience age-related bone loss that leads to lesser outdoor activities and sunlight 
exposure.11 Besides, lactose intolerance are common in older adults, especially African 
Americans. People with lactose intolerance exclude dairy products (milk, yogurts), which are 
rich sources of vitamin D; this can be a risk factor for vitamin D deficiency.11 
 Since vitamin D is fat-soluble, its efficient absorption is dependent on the gut’s ability 
to absorb fat. People with inflammatory bowel diseases are prone to fat malabsorption, which 
significantly reduces absorption of vitamin D.11 In addition, obesity level is also associated 
with lowered serum 25(OH)D.27 Vitamin D is stored in adipose tissue, and thus it could be 
sequestered in the larger body pool of fat and not released into the circulation in obese people. 
Due to the sequestration of vitamin D in fat tissue, only little amount of vitamin D is available 
for the hydroxylation process in the liver of obese individuals compared with non-obese 
individuals. The decreased bioavailability of vitamin D in obese individuals lead to the 
consistent observation of lower serum 25(OH)D level.27 
 According to Dong et al. (2013), vitamin D intake during early life is associated with 
a lower risk of type 1 diabetes (T1D) in which vitamin D has a protective effect against the 
disease.9 The beneficial effects of vitamin D involve the regulation of immune system, 
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including its action in macrophages, monocytes, T and B lymphocytes.9 Besides the effect on 
T1D, vitamin D metabolism also plays a potential role in the development of T2D by 
affecting either insulin sensitivity or β cell function, or both.5 The research found a positive 
correlation of serum 25(OH)D concentration with insulin sensitivity and the negative effect of 
vitamin D deficiency on β cell function.5 Alternatively, the consumption of vitamin D 
supplementation might enhance insulin sensitivity and β cell function.28 A one-year 
prospective study done by Alkharfy et al. (2013) among adult Saudi patients with or without 
T2D concluded that vitamin D supplementations in combination with insulin and oral agents 
therapeutic regimen improved the level of serum 25(OH)D and attenuated the risk of 
cardiovascular disease among patients with T2D.28  
 While there is an inconsistency in public policy statement between the recommended 
serum 25(OH)D and vitamin D intake necessary to achieve recommended level, the Institute 
of Medicine recommends that the adequate intake of vitamin D for children below 12 months 
is 400IU, whereas adults aged < 70 years and ≥ 70 years required 600IU and 800IU vitamin 
D/day, respectively.11 Keith et al. (2011) showed that vitamin D intake levels among African 
American are below US recommendations, which categorizes the group to have potentially 
higher risk of T2D.29 According to Forrest and Stuhldreher’s study (2010), vitamin D 
deficiency is more prevalent among African Americans due to their darker skin pigmentation, 
different dietary intake patterns, lower education level, and lower socioeconomic status.30 
Therefore, being an African American is one of the risk factors for vitamin D deficiency, 
which amplifies the risk of T2D. While cause and effect cannot be determined in a cross-
sectional study, this project may provide evidence for monitoring and treating vitamin D 
levels in African American patients at risk for T2D. 
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Materials and Methods 
Objective: The primary goal of this study was to investigate the relation between vitamin D 
in a person’s diet and the diagnosis of Type 2 Diabetes (T2D) among African Americans aged 
≥ 18 years old.  
Study Design: This study used a cross-sectional research design through a validated food 
frequency questionnaire and collection of data from medical records (IHIS). A total of 23 
participants enrolled in this study in which 8 of them with T2D and 15 of them without T2D. 
The participants are made up of African American patients from a primary care clinic housed 
at The Ohio State University Hospital East.   
 A short screening process was done orally with the participants regarding their age and 
ethnicity (Appendix B). Any individual who was the patient at the clinic was eligible for the 
screening. Patients who were screened successfully (either diagnosed with T2D or not) will 
complete a short food frequency questionnaire (Appendix C) with the researcher in a private 
room, which last for 10-15 minutes. Only the PI and key personnel will have the access to any 
documents completed by the participants. The participants’ name and identifying information 
were not included in any publications, and were deleted once the study was completed.    
Recruitment: Participants were recruited through personal invitation from the researcher 
during their clinic visit. In addition, flyers advertisements (Appendix A) were used for 
recruitment. The flyer stated that the purpose of the study was to investigate the association of 
vitamin D dietary intake level and T2D diagnosis and that participant would receive a $10 gift 
card in exchange for their participation.  
Evaluation Instrument: The short food frequency questionnaire was derived from the 1992 
version of the Block-National Cancer Institute Health Habits and History Questionnaire 
(HHHQ) and USDA’s National Nutrient Database for Standard Reference. Since this study 
aimed to estimated only dietary intakes of vitamin D, the screening instrument includes only 
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21 food and beverages listed on the HHHQ and USDA’s National Nutrient Database for 
Standard Reference that contain vitamin D.31-33 The screening instrument was designed to ask 
participants how frequently they consume each food or beverage and their usual serving size 
(Appendix C).   
 The interview process with the participants included the following questions:  
Ø Are you African American? 
Ø Are you taking any vitamin D supplements?  
Ø How much time did you spend doing outdoor activities during the past summer 
(June – August)?  
 Participants’ medical records including height, weight, HbA1C, glucose level, serum 
25(OH)D level, smoking status, and medical history (diagnoses and medications/ 
supplements) were assessed through Integrated Health Information System (IHIS) at the 
clinic.  
Statistical Analysis: The statistical analysis estimated the differences in vitamin D dietary 
intake level between the group with T2D and without T2D as well as potential covariates of 
age, gender, sunlight exposure, lactose intolerance, glucose, HbA1C, serum 25(OH)D level. 
Unpaired t-tests were used to determine differences in vitamin D intake levels (dietary only 
and dietary + supplement). Significance was set at p< .05. 
Outcome Measures: The following outcomes are the intended measures used to study the 
association of vitamin D dietary intake and T2D diagnosis among African Americans.  
Ø Average vitamin D values (IU/day) were calculated by using the IU/100g 
values published in Blalock, Norton, Patel, Cabral, & Thomas (2003)34 and 
USDA’s National Nutrient Database for Standard Reference35.   
Ø  Participants’ T2D diagnosis was confirmed through their medical record 
assessed from IHIS.  
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Ø Average contribution of vitamin D dietary intake from individual food and 
beverage were calculated by multiplying frequency of consumption by the 
amount of vitamin D in the food/beverage. 
Ø Serum fasting glucose, HgA1C, and serum 25(OH)D were recorded from the 
patient’s record. The most recent values for each were recorded. 
Results 
 Twenty-three people volunteered to participate in the study. One participant was 
excluded because researchers were not able to obtain a weight measurement. Table 1 presents 
the characteristics of study participants by diabetes status. The results showed that the 
majority of the participants were without diabetes (68.2%), females (50%), age between 21-
50 years (59.1%), and all of them were African American. Out of 22 participants, 13 (59%) 
were obese with a BMI ≥ 30. The participants’ mean height, weight, and BMI are shown in 
Table 1. 
Table 1. Characteristics of Study Participants. 
 With Type 2 Diabetes N (%) Without Type 2 Diabetes N (%) 
Gender: 
Male 
Female 
 
2 (9.1%) 
5 (22.7%) 
 
4 (18.2%) 
11 (50.0%) 
Age (y): 
21-50 
51-65 
 
  1 (4.5%) 
6 (27.3%) 
 
13 (59.1%) 
2 (9.1%) 
Total 
 
 
7 (31.8%) 
 
15 (68.2%) 
 With Type 2 Diabetes (mean ± SD) Without Type 2 Diabetes (mean ± SD) 
Average Height 
(in) 
66.7 ± 6.2  
(n=22) 
66.68 ± 2.6 
(n=22) 
Average Weight 
(lb) 
219.6 ± 83.3 
(n=22) 
214.5 ± 68.8 
(n=22) 
Average BMI 
(kg/m2) 
33.9 ± 8.3 
(n=22) 
33.9 ± 10 
(n=22) 
Sunlight Exposure 
(minutes/day) 
51.4 ± 70.8 
(n=22) 
94 ± 122.6 
(n=22) 
Serum Vitamin D 
(ng/mL) 
17 ± 6.6 
(n=2) 
22.4 ± 10.4 
(n=6) 
HgbA1c 8.4 ± 1.2 
(n=6) 
NA 
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 The average HbA1C level between the participants with T2D (n=7) was 8.4%. No 
differences were detected in serum 25(OH)D level between the two groups (p=.53). Though 
those without T2D reported more sunlight exposure, this was not statistically significant    
(p=.29) (Table 1). 
 Table 2 shows the mean daily vitamin D intakes as estimated by the HHHQ and 
USDA’s National Nutrient Database for Standard Reference. The average vitamin D foods 
and beverages intake of participants with T2D was lower than the participants without T2D, 
but the values were not statistically significant (p=. 34). The average vitamin D and 
supplementation intake level between groups was not statistically significant (p=. 22) despite 
the higher values in participants with T2D compared to participants without T2D. None of the 
participants in this study meet the recommended dietary allowances (RDA) for vitamin D 
dietary intake of 600IU/day, without supplementation. 
Table 2. Average Daily Vitamin D Intakes (IU/day) 
 With Type 2 Diabetes Without Type 2 Diabetes 
Average Vitamin D Dietary 
Intake (IU/day) 
98.2 ± 66.8 
(n=7) 
157.0 ± 149.7 
(n=15) 
Average Vitamin D + 
Supplement Intake 
(IU/day)* 
 
776.7 ± 1632.9  
(n=6)  
 
674.1 ± 770.1 
(n=14)   
* Two participants with supplementation higher than 7,000 IU/day were excluded. 
Correlation between vitamin D dietary intake level (no supplementation) and the serum 
25(OH)D level was found to be r2 = 0. Correlation between vitamin D intake with 
supplements and the serum 25(OH)D level among participants was r2 = . 21.  
The percentages of vitamin D contributed by each food and beverage from the 
participants were listed on the screening instrument as shown in Figure 2. The participants 
consumed eggs, pink salmon, milk on cereal, fortified orange juice, skim milk, and 2% milk 
at a higher percentage compared to other foods. 
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Discussion 
 While not statistically significant, our findings suggest that African Americans at a 
primary care clinic in Central Ohio with T2D tend to have lower vitamin D dietary intakes 
compared with people without T2D, but all African Americans regardless of diabetes 
diagnosis did not meet dietary recommendations for vitamin D. While there are inconclusive 
results on the mechanism action of vitamin D in T2D, studies showed that vitamin D play a 
potential role in regulating glucose transport and insulin secretion in the development of 
T2D.5,6  
 According to the study by Keith et al. (2011), vitamin D intake levels among African 
American are below US recommendations (<600IU/day), which was in the same direction 
with the findings in this study in which participants with and without T2D have an average of 
0%	   2%	   4%	   6%	   8%	   10%	   12%	   14%	   16%	   18%	  Whole	  Milk	  
2%	  Milk	  1%	  Milk/	  Skim	  Milk	  
Milk	  in	  Coffee/Tea	  Soymilk	  
Forti=ied	  Orange	  Juice	  Mixed	  dishes	  with	  cheese	  
Cheese	  spreads	  Biscuit	  or	  muf=ins	  
Ice	  cream	  Yogurt/	  Frozen	  Yogurt	  
Milk	  on	  cereal	  Oyster	  
Shrimp	  Pink	  salmon	  
Tuna	  Liver	  
Eggs	  High	  =iber	  cereal	  
Sausages/	  Luncheon	  Meat	  Mushroom	  
Figure	  2.	  Average	  Percentages	  of	  Dietary	  Vitamin	  D	  From	  Individual	  Foods	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low vitamin D intake of 98.2 ± 66.8 IU/day and 157.0 ± 149.7 IU/day, respectively. The 
reasons for the statistically insignificant results on the average vitamin D dietary intake level 
(no supplementation) between the two groups of participants might due to the relatively small 
number of participants (n=22) in this study. In addition, there was no correlation found 
between the vitamin D dietary intake level (no supplementation) and the serum 25(OH)D 
level. A week positive correlation was also found between vitamin D intake with supplements 
and the serum 25(OH)D level among the participants. 
  The results (Figure 1) showed that participants in this study consumed a higher 
percentage of eggs, pink salmon, milk on cereal, fortified orange juice, 1% skim milk, and 
2% milk compared to other foods and beverages. 1% skim milk and 2% milk were consumed 
at a higher percentage over whole milk, because the participants in this study were mainly in 
the obese category and if not were overweight. The milk supply in the U.S is voluntarily 
fortified with 100IU/cup of vitamin D; therefore, is a great source of vitamin D. Out of 22 
participants, however, ten participants did not consume any milk because they believed they 
were lactose intolerance. The lactose intolerance status was not documented in their medical 
records. Participants without T2D consumed higher level of fortified orange juice, because 
those with T2D were concerned about the high sugar level in the drink. Majority (n=16) of 
the participants consumed milk on cereal. Pink salmon made up a high percentage mainly due 
to its high level of vitamin D and was consumed by a number of participants (n=10). Eggs 
were also a great source of vitamin D that was consumed by majority (n= 18) of the 
participants. 
 There are a number of potential limitations in this study. First, the small sample size 
(n=22) of the study reduces the power to detect significant relationships between the data of 
the study. Second, there is a large variation in vitamin D supplementation dosage, in which 
ergocalciferol supplementation contains 50,000 units in one capsule and was consumed once 
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in a week, while cholecalciferol supplementation contains either 1000 or 2000 units in one 
tablet and was consumed daily. Third, sun exposure measurement was based on one question, 
which limits the accuracy. Besides, the measurement was not converted into IU/day and 
added to the total vitamin D for participants, which might underestimate the vitamin D level 
of the participants. Lastly, the dietary intake was self-reported; therefore, it is possible that the 
participants might have over- or underestimated the intake level for each food and beverage.  
 This study also has some significant strengths. Participants in this study are patients 
from the clinic and met the target participants all with African American’s ethnicity. Besides, 
it used medical record through IHIS to verify participants’ diabetes status. Furthermore, this 
study used a validated FFQ designed to estimate the usual intake of vitamin D, which 
provides reasonably accurate estimates of vitamin D intake of the participants.  
Conclusion and Implications 
  In conclusion, we found that participants with T2D have a lower vitamin D intake level 
compared to participants without T2D. Although the findings were not statistically 
significant, it may be clinically significant for improving treatment of T2D. In regards to the 
low vitamin D dietary intakes among the patients, the primary care clinic may wish to provide 
nutrition education on the importance of vitamin D to all African American patients. In 
addition, the clinic should make the screening of vitamin D deficiency a necessary procedure 
for every African American patient in order to prevent any detrimental consequences that are 
associated with vitamin D deficiency, such as increased risk of having T2D, cardiovascular 
disease, and cancer19.  
 With the growing diabetes mortality rates and increasing healthcare costs for 
diagnosing and treating the disease, it is essential to confirm the beneficial effects of vitamin 
D in order to prevent the progression of pre-diabetes to diabetes. If these results are 
confirmed in prospective studies over a large sample size examining the association between 
 18 
vitamin D intake level, serum 25(OH)D, and T2D risk or in randomized trials of vitamin D 
supplementation, they may have important public health implications and provide a simple, 
effective, and low cost dietary intervention to stem the tide of the increasing rates of diabetes. 
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